Oxford Bioscience Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Investments
-
222
- Portfolio
-
5
- Exits
-
130
Oxford Bioscience Partners General Information
Description
Oxford Bioscience Partners was an early-stage venture capital investment firm that was based in Boston, Massachusetts. The firm invested in life sciences and healthcare sectors with a focus on technology, medical devices, instruments and systems, and therapeutics companies. Oxford invested in pre-commercial stage businesses that solve problems throughout the international life science market.
Contact Information
Website
www.oxbio.com
Year Founded
1992
Investor Status
Out of Business
Primary Investor Type
Venture Capital
Primary Office
- P.O. Box 207
- 12 Giles Place
- Mansfield, MA 02048
- United States
Oxford Bioscience Partners Investments (222)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Yolia Health | 01-Jan-2017 | Later Stage VC | 000 | Therapeutic Devices | Generating Revenue | 00000000 0000000 |
| 0000000000 0000000 | 15-Jun-2015 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 00000000 0000000 |
| 0000000 | 19-Nov-2014 | 00000 00000 | Energy Storage | Out of Business | 0000000 00000 | |
| 00000 (0000 000000 | 28-Apr-2014 | 00000 00000 | Food Products | Generating Revenue | ||
| 00000000 000000000 | 30-Aug-2013 | 00000 00000 | 000.00 | Pharmaceuticals | Out of Business | 0000 000000 |
| 00 0000000000 | 01-Aug-2013 | 00000 00000 | 00.000 | Biotechnology | Generating Revenue | |
| 0000000 0000000000 | 01-Aug-2013 | 00000 00000 | 0000 | Pharmaceuticals | Generating Revenue/Not Profitable | 0000000 000000000 000 |
| 0000 000000000000 | 17-Jan-2013 | 00000 00000 | 000 | Energy Production | Out of Business | 0000000 00000 |
| PharmAbcine | 11-Jun-2012 | Early Stage VC | 00.00 | Drug Discovery | Generating Revenue | 0. 00000000000 000 00.0 |
| Mitralign | 16-May-2012 | Later Stage VC | 0000 | Surgical Devices | Profitable | 0000000 000000 |
Oxford Bioscience Partners Exits (130)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| GreenLight Biosciences | 04-Feb-2022 | Reverse Merger | 00000 |
| 0000000 0000000000 | 07-Sep-2021 | 000000000000000000 | |
| 0000000 0000000000 | 27-Dec-2019 | 0000000000: 000000 | |
| 00 0000000000 | 26-Dec-2019 | 000 | 000.00 |
| 000000000 | 12-Mar-2019 | 000000000000000000 | |
| 00000000000 | 21-Nov-2018 | 000 | |
| 00000000 000000000 | 22-Nov-2017 | 000 00 00000000 | |
| 0000000 0000000000 | 03-Nov-2017 | 0000000 000000 | |
| Selventa | 30-Jun-2017 | Out of Business | |
| Glori Energy | 24-Mar-2017 | Merger/Acquisition |
Oxford Bioscience Partners Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Oxford Bioscience Partners Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Oxford Bioscience Partners Team (27)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Daniel Cole | Venture Partner | 00 | 0 | 0 | Boston, MA |